IMF Videos Search Content For Healthcare Professional (132) Healthcare Provider (132) Care Partner (67) Patient (67) Series - Any - ASCO/EHA (51) ASH (69) Ask Dr. Durie (23) Black Swan Research Initiative (2) Emerging Therapies (3) Facebook Live (6) IMWG (4) Living Well with Myeloma (2) Myeloma in a Minute (5) Myeloma Made Simple (5) Myeloma University (4) Patient & Family Webinar (1) Q&A (11) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (68) High-Risk Myeloma (45) High-risk Smoldering Myeloma (38) Late Relapse (4–6 Lines of Therapy) (84) MGUS (39) Newly Diagnosed (Pre-Treatment or First Treatment) (63) Smoldering Myeloma (49) Types of Therapy Immunomodulatory drugs (IMiDs) (60) Immunotherapies (CAR T; BiTE, etc.) (100) Monoclonal antibodies (54) Proteasome inhibitors (46) Stem cell transplant (38) Steroids (42) Supportive Care (43) Year Published 2026 (20) 2025 (32) 2024 (52) 2023 (43) 2022 (17) 2021 (12) 2020 (1) 2019 (10) 2018 (2) 2017 (1) 2016 (2) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (20) Dr. María-Victoria Mateos (7) Dr. Saad Usmani (3) Dr. Shaji Kumar (2) Dr. Sigurður Kristinsson (2) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (1) Donna Catamero, ANP-BC, OCN, CCRC (1) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Updated results from iMMagine-1: Phase 2 study of anitocabtagene autoleucel for relapsed/refractory multiple myeloma July 18, 2025 ASCO/EHA Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone in NDMM: MRD Negativity Rates and Safety July 17, 2025 ASCO/EHA Long-term Outcomes of Cilta-cel in Relapsed/Refractory Multiple Myeloma July 17, 2025 ASCO/EHA Multiple Myeloma Q&A: Why Diagnosis Can Take 12+ Months, MGUS, Costs & FDA News July 10, 2025 Q&A Myeloma University | Bispecifics in Multiple Myeloma July 7, 2025 Myeloma University Top Myeloma Research Presented at ASCO, EHA & IMWG 2025 Webinar: The Patient Perspective July 1, 2025 ASCO/EHA Elranatamab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: MagnetisMM-6 June 27, 2025 ASCO/EHA CAR-T Therapy in RR AL Amyloidosis: NEXICART-2 Trial Safety and Efficacy June 23, 2025 ASCO/EHA First-in-human JNJ-79635322 trispecific antibody study in RRMM patients: Initial phase 1 results June 19, 2025 ASCO/EHA IMWG Conference Series 2025: Making Sense of Treatment June 17, 2025 IMWG Top 10 Myeloma Questions Answered: CAR T, New Drugs & Exercise Tips June 5, 2025 Q&A What Really Causes Multiple Myeloma? What Doctors Know So Far in 60 Seconds May 22, 2025 Myeloma in a Minute Load More
